- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · May 14, 2025 | 30.3M sh |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $2.96M |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $1.68M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $4.98M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $6.12M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $5.27M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $6.97M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $18.55M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $17.88M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $25.66M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $26.21M |
| Shares Diluted restated | Q3 2025 · Mar 31, 2024 | 30.74M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 30.05M sh |
| Capex | Q3 2025 · Mar 31, 2024 | $407K |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | $1.13M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $18.91M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $18.57M |
| Stockholders Equity | Q3 2025 · Sep 30, 2023 | $18.89M |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | $18.86M |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $0.01 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.01 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.01 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.01 |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $893K |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $2.75M |
| Net Income | Q3 2025 · Mar 31, 2024 | $285K |
| Net Income | Q3 2025 · Mar 31, 2024 | −$156K |
| Net Income | Q3 2025 · Dec 31, 2023 | −$382K |
| Net Income | Q3 2025 · Sep 30, 2023 | −$59K |
| Operating Income | Q3 2025 · Mar 31, 2024 | $355K |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$151K |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $1.25M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $2.6M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $11.9M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $34.97M |